Aquestive Therapeutics (AQST) Prepaid Assets (2017 - 2026)

Aquestive Therapeutics' Prepaid Assets history runs 10 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• On a quarterly basis, Prepaid Assets rose 57.35% year-over-year to $4.5 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 57.35% increase from a year earlier, with the FY2025 full-year figure at $4.2 million, up 26.84% from the prior year.
• Prepaid Assets advanced to $4.5 million in Q1 2026 per AQST's latest filing, from $4.2 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $4.5 million in Q1 2026 and bottomed at $1.2 million in Q2 2024.
• The 5-year median for Prepaid Assets is $2.1 million (2024), against an average of $2.4 million.
• Across the five-year window, Prepaid Assets tumbled 31.05% in 2023 and soared 77.24% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $2.1 million in 2022, then dropped by 13.0% to $1.9 million in 2023, then surged by 77.24% to $3.3 million in 2024, then climbed by 26.84% to $4.2 million in 2025, then rose by 8.35% to $4.5 million in 2026.
• Per Business Quant, the three latest AQST Prepaid Assets figures stand at $4.5 million (Q1 2026), $4.2 million (Q4 2025), and $2.9 million (Q3 2025).